This arrangement is not a classic partnership , as Amarantus is maintaining all intellectual property rights to current and future versions of LymProat the current time. This is a services agreement that gets the ball rolling on the CLIA process as we make progress on our ongoing LP-002 clinical study and puts Icon in a sub-contractor relationship with respect to LymPro. -
These are the words that jump out to me.
adding "current time" in there could imply thinks may change shortly
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links